Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-17-006531

Chief Medical Officer bought 5,000 shares at $1.11 ($5,550)

From the SEC's structured data for this filing

Trades in this filing

Berger Mark Stanley · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-06-15 Purchase : show line 1 in the form +5,000 $1.11 $5,550 5,000 D
Open-market purchases · 5,000 sh · avg $1.11 · $5,550
Loading xslF345X03/f4061517berger_actinium.xml…